Skip to main content
. 2023 Jun 26;67(7):e01448-22. doi: 10.1128/aac.01448-22

TABLE 3.

Final model of the change in QTcF after dosea

Parameter Value (% RSE)
Typical ΔQTcF in all participants, θTYP (ms) 3.7 (44.6)
Effect of taking both clofazimine and moxifloxacin on ΔQTcF, θCFZ+MFX (ms) 13.0 (55.4)
Effect of age on ΔQTcF, θage (ms/yr) 1.3 (24.6)
Effect of predose QTcF on ΔQTcF, θQTcF0 (ms/10 ms) −3.4 (14.0)
Between-subject variability, ηBSV (ms) 7.2 (20.8)
Between-occasion variability, ηBOV (ms) 9.2 (12.8)
Residual additive error, ε (ms) 11.1 (4.2)
a
Abbreviations: RSE, relative standard error; ΔQTcF, change in QTcF (ms) after drug administration; QTcF, QT interval corrected by Fridericia formula; ΔQTcF values after drug administration for levofloxacin-based regimens (ΔQTcFLFX) and moxifloxacin- or clofazimine-based regimens (ΔQTcFMFX/CFZ) were described as a function of age (θage), predose QTcF (i.e., QTcF at time zero [QTcF0]), and concomitant drug use as described below:
ΔQTcFLFX=θTYP+θage×(age2.83)+θQTcF0×(QTcF036310)+ηBSV+ηBOV+ε
ΔQTcFMFX/CFZ=θTYP×(1+θCFZ+MFX)+θage×(age2.83)+θQTcF0×(QTcF036310)+ηBSV+ηBOV+ε